About Us » Our Facilities

Facilities for Therapeutic Antibody Business

Nanjing, China
ADD R&D center

  • For preclinical, clinical phase I
  • Compliant with GMP regulation in US, CN
  • Total construction area: 8,640 sqm

Accumulated Capability: 400 L

cGMP manufacturing center (under construction)

  • For preclinical, clinical phase I/II
  • Compliant with GMP regulation in US, CN

Accumulated Capability: 2,600 L

Zhenjiang, China
Commercial manufacturing center (planning)

  • For Clinical phase I/II/III and commercial manufacturing
  • Compliant with GMP regulation in US, CN

Accumulated Capability: 16,800 L

Facilities for Cell and Gene Therapy Business

Zhenjiang, China
Plasmid process development center

  • Qualified for preclinical plasmid preparation, plasmid process development, plasmid for clinical phase I
  • 5 L-100 L stainless steel fermenter

Lot area: 1,200 sqm

GMP virus clinical manufacturing center

  • Qualified for preclinical virus preparation, virus process development, clinical phase I/II
  • Compliant with GMP regulation in US, CN
  • Adherent culture line
  • Suspension culture line

Lot area: 2,500 sqm

GMP plasmid clinical manufacturing center (under construction)

  • Qualified for clinical phase I/II
  • Compliant with GMP regulation in US, CN

Lot area: 4,800 sqm

Commercial manufacturing center (under construction)

  • Qualified for clinical phase I/II/III and commercial manufacturing
  • Compliant with GMP regulation in US, CN

Lot area: 30,000 sqm